Biopharmaceutical company Mogrify has taken its Series A financing to £24 million after raising �...
Oxford Nanopore Technologies has raised £195 million. The firm, spun out of Professor Hagan B...
SoftBank has backed an Oxford-based AI drug discovery company in a Series D funding round wor...
Cambridge BioTech Healx has appointed a former key figure at Dyson as VP of artificial intelligenc...
A BioTech company which produces synthetic antibodies has launched a new product that could improv...
A team of scientists from the University of Bristol have announced the formation of a new BioTech ...
A specialist drug discovery company has secured £2.7 million in new equity financing. Metrion�...
A Cambridge biopharmaceutical company has been acquired in a deal potentially worth £1 billion by ...
An Oxford University spin-out has raised £7.3 million to develop a device which could prevent brai...
Oxford Nanopore Technologies has revealed plans to float on the London Stock Exchange later this ...
A BioTech company which has developed a rapid test that could be a ‘game-changer’ in combating...
Oxford Medical Products has raised £1.2 million to develop a weight loss technology which could hel...